Dataset 5 comprises gene expression profiles created by the overexpression of the ABCC1 gene, which was recently recognized as an Alzheimer’s disease (AD) therapy target15. This evidence concerns the gene ABCC1 and early-onset autosomal dominant Alzheimer disease.